CHD diagnosis defined as either a previous myocardial infarction (MI) or angina pectoris (AP) who were admitted in a hospital for an intended revascularisation intervention (angioplasty and or coronary artery bypass graft (CABG) procedures) Circulatory System
Conditions
Interventions
The study employed a mixed-methods single-arm design with pre-post assessment of patient outcomes and qualitative interviews with healthcare staff involved in the intervention delivery, patients and c
Sponsors
Ibrahim Cardiac Hospital & Research Institute
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Consecutive patients aged =18 years 2. A CHD diagnosis, defined as either a previous myocardial infarction (MI) or angina pectoris (AP) 3. Admitted to a hospital for an intended revascularisation intervention (angioplasty and or coronary artery bypass graft (CABG) procedures) between June and July 2024 4. Deemed suitable for CR participation by the clinical team
Exclusion criteria
Exclusion criteria: 1. Underwent emergency revascularization 2. Had undertaken CR within the last 12 months 3. Had contraindications to exercise testing or exercise training as part of their documented medical history 4. Were unwilling or unable to travel to the clinical site for their research assessments
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Feasibility: 1. Recruitment: the number of consented participants relative to the total number of eligible patients approached for consent, measured using screening logs at 1.5 months 2. Retention: the number of participants who complete the final study assessment relative to the total number of participants enrolled for the pilot trial, measured using study logs at 3-months follow-up 3. Adherence: the percentage completion of the Bangla Heart Manual intervention components measured using training logs at 6 weeks follow-up 4. Adverse events: adverse events (walking, exercise and daily activities time) measured using self-reporting and weekly check-in sessionsat 6 weeks of follow-up Acceptability: 1. Acceptability: participating patients and their caregivers’ acceptability of the intervention and its delivery measured using a questionnaire and qualitative interviews at the end of the 6-week home-based cardiac rehabilitation programme 2. Satisfaction: the satisfaction of patients and their caregivers measured using a questionnaire (0 to 5 Likert scale) at the end of the 6-week home-based cardiac rehabilitation programme | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Sociodemographic characteristics: details of patient’s age, sex etc measured using self-reporting and medical records at baseline 2. Clinical characteristics: details of patient’s clinical status measured using medical records at baseline 3. Exercise and functional capacity measured using Incremental Shuttle Walk Test (ISWT) at baseline and 6-weeks follow-up 4. Hospitalisation measured using self-reporting at 6 weeks follow-up period 5. Mortality measured using medical record at 6 weeks follow-up period 6. Patient reported outcomes will be measured using the Disease-specific Health-Related Quality of Life, (HRQoL), HeartQoL Bangla version questionnaire, Generic specific Health-Related Quality of Life, (HRQoL) and the Generic quality of life five-dimension EuroQol (EQ-5D-5L) Scale at baseline and 6-weeks follow-up 7. Psychological well-being measured using the Hospital Anxiety and Depression Scale (HADS) at baseline and 6-weeks follow-up | — |
Countries
Bangladesh
Contacts
Public ContactMd. Jamal Uddin
Outcome results
None listed